An observational study in High-risk, Bipolar Disorder and Atypical Depression, sponsored by Shanghai Mental Health Center. Recruiting at 1 site in China. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-22.
Sponsored by Shanghai Mental Health Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Bipolar Disorder by Shanghai Mental Health Center — 7 open to participants now, 7 under way, none of them phase 3. Bipolar Disorder · Shanghai Mental Health Center.
Among the 16 studies in Bipolar Disorder by Shanghai Mental Health Center, this one is one of 4 that started in 2024, is one of 8 observational ones, and was the 12th registered.
1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.
Browse Bipolar Disorder studies →7 of the 16 studies in Bipolar Disorder by Shanghai Mental Health Center are open now, in 1 country. Recruiting first, the newest first:
Shanghai Mental Health Center · Sites in China
Ages 18–64 · Healthy volunteers
Shanghai Mental Health Center · Sites in China
Ages 18+
Shanghai Mental Health Center · Sites in China
Ages 18–65
Shanghai Mental Health Center · Sites in China
Ages 13+
Shanghai Mental Health Center · Sites in China
Ages 12+ · Healthy volunteers
By country, each count listing its studies:
Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.
This study: 6 Years to 18 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,200 is above the median of 158 across 349 observational studies indexed under Bipolar Disorder.
Median enrollment 65 across the 8 interventional studies, 1,100 across the 8 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Shanghai Mental Health Center is the lead sponsor of 277 studies on the registry; 95 are open to participants now.
1 of the studies in Bipolar Disorder by Shanghai Mental Health Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06417437Shanghai Mental Health CenterNon-invasive BCI and Application Verification for Depressed People | 2027-07-31 |
Add it to your calendar (.ics) → With an account.
Among the 16 studies in Bipolar Disorder by Shanghai Mental Health Center, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Bipolar disorder (BD) is a serious, complicated, familial aggregation onset of mental illness, which has the characteristics of five-low and one-high, namely high prevalence, high recurrence rate, high morbidity and mortality, high comorbidity rate and younger age characteristics. This situation will seriously influence one's behaviour or thinking, cognitive, emotional, social and occupational function, causing the heavy burden of disease. But, early recognition and early diagnosis are difficult to achieve at present.
Based on the preliminary research results of the project team, it is found that BD can be identified early through specific dimensions, and early recognition is crucial for the prognosis of patients. The earlier the intervention for BD is implemented, the better the prognosis, especially the functional prognosis, but the difficulty lies in how to implement it. Establishing a high-quality clinical cohort of BD high-risk population is a necessary prerequisite. This study intends to establish a high-quality, large-sample cohort through multi-center, long-term and prospective cohort design and enroll 100 BD high-risk patients every year, a total of 400 cases in 4 years. The electronic mental health service platform will be used for ten years of intensive follow-up. Multi-modal data including clinical characteristics, genetic, cognitive, neuroimaging, sleep monitoring, eeg, eye movement, speech, facial expression and movement were collected to construct the database. On this basis, the interaction of biological factors, clinical risk factors, and environmental risk factors in the onset of BD is discussed to establish a big data prediction model for BD onset in high-risk populations. The effective subgroups of early intervention were analyzed and screened. An ethical and individualized prediction model of the effectiveness and safety of early intervention for the BD high-risk population was constructed.
It is hoped that the smooth implementation of this project can provide empirical evidence for the early identification, prevention and intervention of BD. To provide clinicians with real data-driven decision-making guidance to assist in selecting personalized and precise treatment; Ultimately promote the prognosis and functional recovery of BD patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
the 6-18 years old health offsprings with at least one parent with bipolar disorder
Other: This was an observational study with no intervention.
the 6-18 years old patients with atypical depression according to the criteria of DSM-5
Other: This was an observational study with no intervention.
health juveniles with age and gender matched with HR-BD
Other: This was an observational study with no intervention.
This was an observational study with no intervention.
The prevelence of mental illnesses over time in all three groups.
The K-SADS-PL or SCID will be used to screen the mental illnesses of all three group. The cumulative prevelence of all follow-up points will be calculated.
Time frame: 4 year, participants will be followed-up every one year.
The differences of developmental trajectory of brain structure and function between three groups.
All participants will complete the brain MRI scan every each year, which including structural MRI, resting-state and task functional MRI. The volume, thickness, Reho, attributes of structural and functional brain networks will be calculated and compared longitudinally.
Time frame: 4 year, participants will be scaned every each year.
The differences of developmental trajectory of multi-model features between three groups.
The electroencephalogram (EEGs), eye movement, Polysomnography (PSG), voice, expression and gait movement will be recorded at baseline and annual follow-up period. The features of event-related potentials like N1 and P3, event-related spectral perturbation will be extracted from EEG. Saccadic latency, saccadic peak velocity, saccadic amplitude, saccade count, average fixation duration, total fixation duration, visit count, velocity gain, position gain of smooth tracking, accuracy and latency of visual search will be extracted from eye movement records. Total sleep time, sleep efficiency, sleep onset latency, rapid eye movement (REM) sleep latency, awakenings number, wake after sleep onset, number of microarousals, apnea-hypopnea index, time of REM sleep will be analyzed according to PSG. Formant frequency, intensity, bandwidth, Hammarberg Index, Mel-frequency cepstral coefficients (MFCC) will be acquired from voice data. The facial expression entropy and facial action units will be ca
Time frame: 4 year, participants will be followed-up every one year.
The differences of developmental trajectory of cognitive function between three groups.
All participants will be assessed with Wechsler Intelligence Scale for Children (WISC-III) or Wechsler Adult Intelligence Scale (WAIS-III). The total score of WISC-III/WAIS-III and scores of sub-scales will be calculated. Different ranges of total score of WISC-III/WAIS-III imply corresponding intelligence level. Intelligence quotient follows a normal distribution among the general population, with a mean of 100 and a standard deviation of 15. The higher the total score, the better the cognitive function.
Time frame: 4 year, participants will be followed-up every one year.
The differences of quality of sleep between three groups.
All participants will be assessed with Sleep Disturbance Scale for Children (SDSC)/Pittsburgh Sleep Quality Index (PSQI). The scores of total scale or subscales will be calculated. The potential range is 26-130 in SDSC and 1-21 in PSQI, the higher the worse of sleep quality.
Time frame: 4 year, participants will be followed-up every one year.
The differences of quality of life between three groups.
All participants will be assessed with Quality of life scale for children and adolescents (QLSCA)/ World Health Organization Quality of Life - BREF (WHOQOL-BREF). The total score will be calculated. The potential range is 0-100 in WHOQOL-BREF, the higher the better quality of life.
Time frame: 4 year, participants will be followed-up every one year.
The differences of genetic phenotypes and between three groups.
The peripheral blood samples of all participants will be collected at baseline and every year, which include 5ml anticoagulant blood sample with EDTA and 5ml procoagulant blood sample. Genotyping carried out using the Illumina Genome wide Asian Screening Array (ASA) Assay. SNP of ANK3、SCN2A、CACNA1C、KCNB1、TRANK1、NCAN、HOMER1 will be selected. New genes will also be detected by GWAS.
Time frame: 4 year, participants will be followed-up every one year.
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2024 (actual). Primary completion is estimated for Dec 2025, 14 months after the start.
Of 95 non-industry observational studies under Bipolar Disorder, half reached primary completion within 65 months of starting (the median), counting those still running; a quarter within 39 and three quarters within 119. This study's planned 14 months is below that.
Counting every sponsor, half of 105 studies reached it within 64 months; a quarter within 31 and three quarters within 119.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Mental Health Center →